Auscom Biopharmaceutical (Haimen) Co.
Latest round
- Series B
Last raised
- Jul 2020
Total raised
- $110M
Investors
- 12
About Auscom Biopharmaceutical (Haimen) Co.
, Ltd., Ltd. operates in Linjiang, China. The company focuses on providing integrated CMC solutions for the biopharmaceutical sector.Auscom Biopharmaceutical specializes in integrated CMC (Chemistry, Manufacturing, and Control) solutions for the biopharmaceutical industry. Their diverse product range includes disposable bioreactors in sizes such as 50L, 200L, 500L, and 2000L, as well as customized coupling reactors and advanced ADC (Antibody-Drug Conjugate) development services.Auscom Biopharmaceutical generates revenue through a structure that includes partnerships and B2B transactions with pharmaceutical companies. The company aims to enhance their product offerings and explore opportunities in emerging regions within Asia and Europe over the next few years.
Who invested in Auscom Biopharmaceutical (Haimen) Co.
12 investors across 2 rounds
See all investors in Auscom Biopharmaceutical (Haimen) Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Auscom Biopharmaceutical (Haimen) Co.
Who invested in Auscom Biopharmaceutical (Haimen) Co.?
Auscom Biopharmaceutical (Haimen) Co. has 12 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Auscom Biopharmaceutical (Haimen) Co. raised?
Auscom Biopharmaceutical (Haimen) Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Auscom Biopharmaceutical (Haimen) Co. last raise money?
Auscom Biopharmaceutical (Haimen) Co.'s most recent round on record is a Series B, in Jul 2020.
What does Auscom Biopharmaceutical (Haimen) Co. do?
Auscom Biopharmaceutical (Haimen) Co. is a biotechnology company.
Where is Auscom Biopharmaceutical (Haimen) Co. headquartered?
Auscom Biopharmaceutical (Haimen) Co. is headquartered in Linjiang, China.
Which VCs invest in companies like Auscom Biopharmaceutical (Haimen) Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Auscom Biopharmaceutical (Haimen) Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Auscom Biopharmaceutical (Haimen) Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.